Evolution of TAVI patients and techniques over the past decade: The French TAVI registries.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 21 02 2022
revised: 07 04 2022
accepted: 11 04 2022
pubmed: 9 5 2022
medline: 18 5 2022
entrez: 8 5 2022
Statut: ppublish

Résumé

The French transcatheter aortic valve implantation (TAVI) registries, linked with the nationwide administrative databases, have collected data on TAVI procedures from the first experience to current practices. To investigate changes over the past decade in patient and procedural characteristics, major complications and mortality after TAVI. Data from the France TAVI and FRANCE 2 registries, collected between 2010 and 2021, were linked using a probabilistic algorithm to the French national health single-payer claims database (SNDS). The algorithm created patient profiles from TAVI procedures in SNDS, matching them as closely as possible to the profiles in the registry databases. A total of 84,783 TAVI patients were included during the study period. The median age was 83 years (quartile 1, 79 years; quartile 3, 87 years) and remained stable over time. The median EuroSCORE 1 surgical risk score was 12.8 (quartile 1, 7.9; quartile 3, 21.0), and decreased over time. The number of procedures increased linearly, from 1556 in 2010 to 14,114 in 2021. The prevalence of iliofemoral access increased, whereas use of the other approaches decreased. Rates of in-hospital, 30-day and 1-year mortality per year were lower in patients undergoing TAVI after 2015, regardless of the surgical risk score. Finally, hospital length of stay decreased progressively, from 8 days in 2010 to 4 days in 2021. The TAVI registries provide the cornerstone for recording changes in TAVI. Over the past decade, patient profiles have improved whereas their age has remained stable. Simplification of the procedure reduced rates of death and major complications as well as length of hospital stay.

Sections du résumé

BACKGROUND BACKGROUND
The French transcatheter aortic valve implantation (TAVI) registries, linked with the nationwide administrative databases, have collected data on TAVI procedures from the first experience to current practices.
OBJECTIVE OBJECTIVE
To investigate changes over the past decade in patient and procedural characteristics, major complications and mortality after TAVI.
METHODS METHODS
Data from the France TAVI and FRANCE 2 registries, collected between 2010 and 2021, were linked using a probabilistic algorithm to the French national health single-payer claims database (SNDS). The algorithm created patient profiles from TAVI procedures in SNDS, matching them as closely as possible to the profiles in the registry databases.
RESULTS RESULTS
A total of 84,783 TAVI patients were included during the study period. The median age was 83 years (quartile 1, 79 years; quartile 3, 87 years) and remained stable over time. The median EuroSCORE 1 surgical risk score was 12.8 (quartile 1, 7.9; quartile 3, 21.0), and decreased over time. The number of procedures increased linearly, from 1556 in 2010 to 14,114 in 2021. The prevalence of iliofemoral access increased, whereas use of the other approaches decreased. Rates of in-hospital, 30-day and 1-year mortality per year were lower in patients undergoing TAVI after 2015, regardless of the surgical risk score. Finally, hospital length of stay decreased progressively, from 8 days in 2010 to 4 days in 2021.
CONCLUSION CONCLUSIONS
The TAVI registries provide the cornerstone for recording changes in TAVI. Over the past decade, patient profiles have improved whereas their age has remained stable. Simplification of the procedure reduced rates of death and major complications as well as length of hospital stay.

Identifiants

pubmed: 35527212
pii: S1875-2136(22)00073-0
doi: 10.1016/j.acvd.2022.04.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-213

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Auteurs

Romain Didier (R)

University Hospital of Brest, 29200 Brest, France.

Herve Le Breton (H)

University Hospital of Rennes, Rennes, 35000 France.

Hélène Eltchaninoff (H)

University Hospital of Rouen, Rouen, 76000 France.

Guillaume Cayla (G)

University Hospital of Nîmes, Nîmes, 30000 France.

Philippe Commeau (P)

Clinique des Fleurs, Ollioule, 83090 France.

Jean-Philippe Collet (JP)

Pitié Salpetrière Hospital, AP-HP, Paris, 75000 France.

Thomas Cuisset (T)

University Hospital of Marseille, La Timone 13000 France.

Nicolas Dumonteil (N)

Clinic Pasteur, Toulouse 31000 France.

Jean-Philippe Verhoye (JP)

University Hospital of Rouen, Rouen, 76000 France.

Sylvain Beurtheret (S)

Saint Joseph Hospital, Marseille 13000 France.

Thierry Lefèvre (T)

Cardiovascular Institute Paris South, Paris, 75000 France.

Bernard Iung (B)

Bichat Hospital, AP-HP, and Université de Paris, Paris, 75000 France.

Martine Gilard (M)

University Hospital of Brest, 29200 Brest, France. Electronic address: martine.gilard@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH